GlassScriptPhysician profile
Daniel R Bachman
NPI 1457794299
$10,854.63
in general payments reported to CMS, 2019-2025
17 companies · $345 in 2025
The $345 reported for 2025 was more than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $63.60 · 2021: $1,411 · 2022: $2,455 · 2023: $5,082 · 2024: $1,055 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,456 · Food and Beverage: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,456.24 |
| Food and Beverage | $1,024.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $4,756.21 | 2023 | Other - Miscellaneous |
| Arthrex, INC. | $1,771.18 | 2022-2024 | |
| Legacy Ortho LLC | $1,200.00 | 2021 | |
| Alpha Orthopedic Systems | $680.32 | 2022-2024 | |
| Blue Surgical LLC | $635.51 | 2024-2025 | |
| Stryker Corporation | $457.69 | 2019-2021 | |
| Medtronic, INC. | $322.01 | 2022-2025 | Stealthstation S8 Platform, Shilla Growth Guidance System |
| Zimmer Biomet Holdings, INC. | $180.42 | 2019-2023 | Rosa |
| Highridge Medical LLC | $165.01 | 2025 | The Tether |
| Depuy Synthes Sales INC. | $158.54 | 2022 | |
| Nuvasive Specialized Orthopedics, INC. | $151.99 | 2023 | Precice Intramedullary Limb Lengthening System |
| Biomarin Pharmaceutical INC. | $121.35 | 2024 | Voxzogo 1.2mg |
| Vericel Corporation | $100.00 | 2019 | |
| Acumed LLC | $47.23 | 2020 | |
| Medacta USA, INC. | $44.94 | 2023 | Myspine |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $34.34 | 2019 | |
| Smith+Nephew, INC. | $27.89 | 2023 | Renasys Touch, Pico 14, Pico 7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Bachman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.